In-contiguity and non-anatomical extension of right hepatic trisectionectomy for liver metastases

被引:15
作者
Lodge, JPA [1 ]
Menon, KV [1 ]
Fenwick, SW [1 ]
Prasad, KR [1 ]
Toogood, GJ [1 ]
机构
[1] St James Univ Hosp, Hepatobiliary & Transplant Unit, Leeds LS9 7TF, W Yorkshire, England
关键词
D O I
10.1002/bjs.4830
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: In some patients undergoing right hepatic trisectionectomy for metastases, extension of the resection beyond the falciform ligament is necessary to achieve tumour clearance. The aim of the present study was to assess the early and long-term outcomes and hepatic function in patients who underwent extensive liver resection beyond right trisectionectomy. Methods: Thirty-eight patients who had extension of a tight trisectionectomy, either in contiguity (IC) or in a non-anatomical (NA) fashion, for liver metastases were included in the study. In-hospital mortality, hepatic function and other morbidity were recorded. Survival outcomes were analysed for the subgroup of patients with colorectal liver metastases. The clinical risk score described by the Memorial Sloan-Kettering Cancer Center was applied to all patients with colorectal liver metastases. Results: Sixteen patients had IC resection, 15 NA resection, and seven had both IC and NA procedures. There was one in-hospital death. Hepatic dysfunction was seen in 25 patients and two developed liver failure. Disease-free actuarial 3-year survival was 42 per cent for patients with colorectal liver metastases. Survival was significantly better in patients with a clinical risk score of 3 or less. Conclusion: Extension of right trisectionectomy for liver metastases was associated with a low risk of death and hepatic failure.
引用
收藏
页码:340 / 347
页数:8
相关论文
共 62 条
[1]   Repeat hepatectomy for colorectal liver metastases [J].
Adam, R ;
Bismuth, H ;
Castaing, D ;
Waechter, F ;
Navarro, F ;
Abascal, A ;
Majno, P ;
Engerran, L .
ANNALS OF SURGERY, 1997, 225 (01) :51-60
[2]  
Adam R, 1998, BRIT J SURG, V85, P1493
[3]   Two-stage hepatectomy: A planned strategy to treat irresectable liver tumors [J].
Adam, R ;
Laurent, A ;
Azoulay, D ;
Castaing, D ;
Bismuth, H .
ANNALS OF SURGERY, 2000, 232 (06) :777-784
[4]   Hepatic resection for colorectal metastases - Analysis of prognostic factors [J].
Ambiru, S ;
Miyazaki, M ;
Isono, T ;
Ito, H ;
Nakagawa, K ;
Shimizu, H ;
Kusashio, K ;
Furuya, S ;
Nakajima, N .
DISEASES OF THE COLON & RECTUM, 1999, 42 (05) :632-639
[5]   Survival after resection of multiple bilobar hepatic metastases from colorectal carcinoma [J].
Bolton, JS ;
Fuhrman, GM .
ANNALS OF SURGERY, 2000, 231 (05) :743-750
[6]  
CADY B, 1992, ARCH SURG-CHICAGO, V127, P561
[7]   Results of hepatic resection for sarcoma metastatic to liver [J].
DeMatteo, RP ;
Shah, A ;
Fong, Y ;
Jarnagin, WR ;
Blumgart, LH ;
Brennan, MF .
ANNALS OF SURGERY, 2001, 234 (04) :540-547
[8]   During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma [J].
Elias, D ;
de Baere, T ;
Roche, A ;
Ducreux, M ;
Leclere, J ;
Lasser, P .
BRITISH JOURNAL OF SURGERY, 1999, 86 (06) :784-788
[9]  
FAN ST, 1995, ARCH SURG-CHICAGO, V130, P198
[10]   Portal vein embolization before right hepatectomy - Prospective clinical trial [J].
Farges, O ;
Belghiti, J ;
Kianmanesh, R ;
Regimbeau, JM ;
Santoro, R ;
Vilgrain, V ;
Denys, A ;
Sauvanet, A .
ANNALS OF SURGERY, 2003, 237 (02) :208-217